In a new study, an experimental obesity drug from Novo Nordisk, CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish company's stock price to fall by as much as 29%. Yes, fall. For anyone not following the heated race for obesity drug dominance, it may look like we're living upside-down. After all, if this data were unveiled three years ago, the market reaction would have been wildly different. The stock might have gone up and headlines would have heralded an advance in the fight against obesity. But we're in a new era of obesity medicine. The bar for success, once modest, has soared—especially so for CagriSema. Let me explain.
Though Novo will make mind-blowing money from its existing obesity drugs in the coming years (its GLP-1 drugs are likely to become pharma's most lucrative franchise next year), CagriSema was seen as essential for continued growth in 2030 and beyond. And the study suggests it may not be the contender investors had hoped for.
この記事は Mint Chennai の January 02, 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Mint Chennai の January 02, 2025 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
The Perks of Reflection and Daily Me-Time
Introspection helps one think more clearly, says Spinny CEO Niraj Singh
Hiring Is Just The First Step Towards Inclusion
Persons with disabilities and those from marginalized groups need mentors and a supportive environment to grow in their careers
It's your touch that will push an AI co-worker to do better
AI agents help break down silos and improve decision-making and collaboration, but it's people who can leverage their benefits
The Digital Data Protection rules have hits and misses
Some provisions can set a global example for age-gating but others would overburden data fiduciaries
The 'Asian Aunty' is smashing ageist and gender stereotypes
'Aunty' leaders are tackling a widely normalized form of 'othering'
Public debt: Do not let it eclipse the fiscal deficit
The Centre's plan to adopt debt as its new focus for budget prudence after 2025-26 does hold merit but we must not lose track of the fiscal gap. It'll remain a valuable economic indicator
Longevity Is Usually A Reward For Being Unspectacular
Careers That Endure Are Typically Not Spectacular. This Is So In Politics As Well As Other Fields
Get public-private partnerships right for target-oriented growth
The UK's new government should engage the private sector with deals that achieve public objectives
How to Use Home Loan Interest as Acquisition Cost
What to do with home loan interest
Inside Sebi's 30-month investigation
Though independent directors do not oversee a company's daily operations, Sebi has said that there is direct evidence of their involvement in the scam.
